ubmslatePT-logo-ubm

PT Mobile Logo

Search form

Topics:

Brian Miller, MD, PhD, MPH

Brian Miller, MD, PhD, MPH

Dr Miller is Associate Professor in the Department of Psychiatry and Health Behavior at Augusta University in Augusta, GA. Current research focuses on inflammation/cytokines as a potential clinical state and relapse predictive marker in schizophrenia, and is funded by an NIMH K23 Mentored Patient-Oriented Research Career Development Award and the NIH Clinical Loan Repayment Program Award. He has been recognized with several young investigator awards, the 2010 Laughlin Fellowship from the American College of Psychiatrists, and a 2011 Exemplary Psychiatrist Award from the National Alliance on Mental Illness. He is the Schizophrenia Section Editor for Psychiatric Times.

Posts by Author

Tardive syndromes include a broad spectrum of abnormal movements. Which movement disorders can resemble tardive dyskinesia? Find out in the quiz.

What are the strongest predictors of suicidality in schizophrenia?

New evidence links vitamin D status with cognition in patients with psychosis.

Which genes have recently been associated with TD? That question and more in this quiz.

New evidence bolsters the reputation of clozapine as the “gold-standard” antipsychotic for patients with treatment-resistant schizophrenia.

Is an effective, well-tolerated treatment for the negative symptoms of schizophrenia on the horizon?

What factors come into play in the diagnosis of tardive dyskinesia? How is TD distinguished from other movement disorders? Find out more in this quiz.

New findings support the involvement of microbiota alterations in psychosis—and point to novel treatments.

Which psychotropic combinations unlock the door to successful treatment?

Do prolactin-elevating antipsychotics put women at risk for endometrial cancer?

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.